Guilleminault(@Guilleminault3) 's Twitter Profileg
Guilleminault

@Guilleminault3

ID:1245265942692737024

calendar_today01-04-2020 08:25:22

691 Tweets

138 Followers

118 Following

Allergy EAACI(@AllergyEaaci) 's Twitter Profile Photo

Mast cell chymase suppresses functional parameters in primary human airway smooth muscle cells. Xinran O. Zhao, Fabio Rabelo Melo, Christian P. Sommerhoff, Aida Paivandy, Gunnar Pejler

Read the article here:doi.org/10.1111/all.16…

Airway remodeling is a key feature in asthma.…

Mast cell chymase suppresses functional parameters in primary human airway smooth muscle cells. Xinran O. Zhao, Fabio Rabelo Melo, Christian P. Sommerhoff, Aida Paivandy, Gunnar Pejler Read the article here:doi.org/10.1111/all.16… Airway remodeling is a key feature in asthma.…
account_circle
Sukhwinder Singh Sohal 🫁(@Romy_Sohal) 's Twitter Profile Photo

Mast cells in smokers and patients with small airway disease and COPD may be associated with airway wall changes and impaired lung function, indicating an active role in maintaining normal tissue homeostasis and, indirectly, in airway architecture bit.ly/3vKxxab

Mast cells in smokers and patients with small airway disease and COPD may be associated with airway wall changes and impaired lung function, indicating an active role in maintaining normal tissue homeostasis and, indirectly, in airway architecture bit.ly/3vKxxab
account_circle
Gerard Filoche(@gerardfiloche) 's Twitter Profile Photo

Pourquoi 75 000 'bénévoles' aux JO 2024 ???
Le bénévolat ça n'existe pas en droit du travail
Or c'est du travail
C’est illégal
Les JO c'est 8,5 milliards
Le chef des JO se paie 22 000 euros par mois Vous devez payer un smic à ces 75 000 jeunes
2  500  000 retweets

account_circle
Allergy & Asthma Network(@AllergyAsthmaHQ) 's Twitter Profile Photo

🎉 Exciting News! U.S. FDA has approved Xolair® for food allergies, a breakthrough in the food allergy community. This biologic drug reduces allergic reactions. Although this is not a cure, it is a new treatment to reduce allergic reactions from accidental exposures.

The drug is…

🎉 Exciting News! @US_FDA has approved Xolair® for food allergies, a breakthrough in the food allergy community. This biologic drug reduces allergic reactions. Although this is not a cure, it is a new treatment to reduce allergic reactions from accidental exposures. The drug is…
account_circle
Juan C Ivancevich MD(@Aller_MD) 's Twitter Profile Photo

Sanofi is moving forward with the development of the CSU medication in a Phase III trial: rilzabrutinib improved itch, hives, and urticaria in a Phase II trial in patients with chronic spontaneous . bit.ly/3TePiYt

Sanofi is moving forward with the development of the CSU medication #rilzabrutinib in a Phase III trial: rilzabrutinib improved itch, hives, and urticaria in a Phase II trial in patients with chronic spontaneous #urticaria. #Sanofi #ClinicalTrials bit.ly/3TePiYt
account_circle
World Allergy Organization(@worldallergy) 's Twitter Profile Photo

: clinical clusters distinguished by blood transcriptome. Discover more through Open Access research. Research sciencedirect.com/science/articl…

#WAOJournal: #Asthma clinical clusters distinguished by blood transcriptome. Discover more through Open Access research. #AsthmaResearch sciencedirect.com/science/articl…
account_circle
Journal of Allergy and Clinical Immunology(@jacionline) 's Twitter Profile Photo

The role of IgE in chronic rhinosinusitis with nasal polyps is undergoing reassessment with new observations from anti-IgE therapy. An Editors’ Choice paper reports that baseline local IgE+cell counts are predictive of omalizumab treatment efficacy. bit.ly/48jo86M

account_circle
ERS publications(@ERSpublications) 's Twitter Profile Photo

ERJ Open Research: ILC1 and ILC2 populations in peripheral blood have different inflammatory profiles in COPD and asthma patients, which may have implications for patient stratification and therapy development bit.ly/48nQtKh

ERJ Open Research: ILC1 and ILC2 populations in peripheral blood have different inflammatory profiles in COPD and asthma patients, which may have implications for patient stratification and therapy development bit.ly/48nQtKh
account_circle
Juan C Ivancevich MD(@Aller_MD) 's Twitter Profile Photo

Adverse effects of anti-IL-5 medications in individuals with have been extensively studied. A comprehensive analysis of randomized controlled trials and real-world evidence has been conducted to assess these events. bit.ly/3HKIPxA

Adverse effects of anti-IL-5 medications in individuals with #eosinophilic #asthma have been extensively studied. A comprehensive analysis of randomized controlled trials and real-world evidence has been conducted to assess these events. bit.ly/3HKIPxA
account_circle